Provenienza dei contatti di primo grado di Martin Forrest
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Martin Forrest tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Biotechnology | Chairman Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | General Counsel Human Resources Officer | |
| The University of Texas at Austin | College/University | Graduate Degree Corporate Officer/Principal | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| TURG POIN | Pharmaceuticals: Major | Chairman Chairman | |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
| Golden Gate University | College/University | Masters Business Admin Graduate Degree | |
| European Organisation for Research & Treatment of Cancer | Corporate Officer/Principal | ||
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Chairman | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member | |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The Indiana University School of Medicine | College/University | Corporate Officer/Principal | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Avon Foundation For Women
 Avon Foundation For Women Investment Trusts/Mutual FundsMiscellaneous Avon Foundation For Women provides granting services. The non-profit company is based in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Chairman | |
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member | |
Median Technologies, Inc.
 Median Technologies, Inc. Medical/Nursing ServicesHealth Services Part of MEDIAN Technologies SA, Median Technologies, Inc. provides medical imaging services. The company is based in Burlington, MA. The CEO of the company is Fredrik Bjjorn Brag. | Medical/Nursing Services | Director/Board Member | |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member | |
Kirilys Therapeutics, Inc.
 Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Medical/Nursing Services | Founder | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Director/Board Member | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Cancer Prevention & Research Institute of Texas
 The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX. | Biotechnology | Corporate Officer/Principal | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The California State University | College/University | Undergraduate Degree | |
Cable & Wireless Ltd.
 Cable & Wireless Ltd. Major TelecommunicationsCommunications Cable & Wireless Ltd. operates as a telecommunications company. The company was founded in 1929 and is headquartered in London, the United Kingdom. | Major Telecommunications | Director of Finance/CFO | |
| SOLARCITY CORP | Building Products | Director of Finance/CFO | |
| Cable & Wireless, Inc. | Director of Finance/CFO | ||
Digital Island, Inc.
 Digital Island, Inc. Internet Software/ServicesTechnology Services Digital Island, Inc. provides network services for e-business applications. The company is based in San Francisco, CA and has subsidiaries in the United States. | Internet Software/Services | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 39 |
| Regno Unito | 5 |
| Canada | 3 |
| Francia | 3 |
| Danimarca | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 7 |
| Health Services | 4 |
| Commercial Services | 3 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 138 |
| Independent Dir/Board Member | 63 |
| Corporate Officer/Principal | 58 |
| Chairman | 25 |
| Undergraduate Degree | 18 |
Contatti più connessi
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| Kapil Dhingra | 39 |
| William Ringo | 32 |
| Lewis Williams | 23 |
| Sheila Gujrathi | 20 |
| David Smith | 17 |
| Garry Nicholson | 16 |
| Carol Schafer | 13 |
| Jonathan Graham | 12 |
| Aron M. Knickerbocker | 11 |
| Lori Lyons-Williams | 11 |
| David White | 10 |
| Jeff P. Coon | 10 |
| Peder Jensen | 10 |
| Francis Sarena | 9 |
- Borsa valori
- Insiders
- Martin Forrest
- Connessioni Società
